Revenue
32.2 thousand USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 32161 USD Source
Fundies. English
Cereplast Inc
EDGARAnnual consolidated revenue for 2025: about USD 837.8K, using the latest reported figures. The previous period, 2024, was about USD 245.6K.
Latest quarter
Operating margin
-296.86%
2026 Q2 · %
Operating cash flow
-7.86 thousand USD
2026 Q2 · USD
- Cash and cash equivalents
- 13.4 thousand USD Source
Exact value
13365 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 74.6 million shares Source
Exact value
74640766 shares
Reported share-count change
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
560 thousand USD
2025-07-01 – 2026-06-30
Net income
-100 thousand USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
Operating cash flow
-37.8 thousand USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: -28822 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -1905 USD · 2025-01-01 – 2025-06-30 Source
- Operating cash flow: -28440 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: -28822 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -3420 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: -11284 USD · 2026-01-01 – 2026-06-30 Source
- Operating cash flow: -3420 USD · 2026-01-01 – 2026-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-09-18.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 2 of 11 periods available· newest 2025-12-31
- Operating income: 6 of 11 periods available· newest 2025-12-31
- Net income: 6 of 11 periods available· newest 2025-12-31
- Operating cash flow: 3 of 11 periods available· newest 2025-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 2 of 11 periods available· newest 2025-12-31
- Total liabilities: 2 of 11 periods available· newest 2025-12-31
- Current assets: 2 of 11 periods available· newest 2025-12-31
- Current liabilities: 2 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 2 of 11 periods available· newest 2025-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 2 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+241.1%Prior period
USD 245,572
–
Current period
USD 837,753
–
Exact inputs and evidence
837753 − 245572 = 592181 USD
245572 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source837753 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 254,173Prior period
−USD 98,844
–
Current period
USD 155,329
–
Exact inputs and evidence
155329 − -98844 = 254173 USD
-98844 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source155329 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 61,142Prior period
−USD 89,582
–
Current period
−USD 28,440
–
Exact inputs and evidence
-28440 − -89582 = 61142 USD
-89582 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-28440 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue USD 837,753 100% of revenue
- Cost of revenue USD 298,108 36% of revenue
- Operating expenses USD 363,167 43% of revenue
- Operating income USD 176,478 21% of revenue
- Tax, interest and other Derived USD 21,149 2.5% of revenue
- Net income USD 155,329 19% of revenue
Cash
- Operating cash flow −USD 28,440 −3.4% of revenue
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2024 Operating loss: operating costs were 139% of revenue.
- 2025 19%79%
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2024 2024-01-01 – 2024-12-31 | 245572 | 341873 Derived | -96301 | 2543 Derived | -98844 | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 837753 | 661275 Derived | 176478 | 21149 Derived | 155329 | Unavailable | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 837.8K 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2024 | Revenue | 245572 |
|
| 2025 | Revenue | 837753 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
241.1% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2024 | Year over year | No prior comparable period |
|
| 2025 | Year over year | 241.1% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin 21.1% 2025
Net margin 18.5% 2025
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2024 | Operating margin | -39.2% |
|
| 2025 | Operating margin | 21.1% |
|
| 2024 | Net margin | -40.3% |
|
| 2025 | Net margin | 18.5% |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -28.4K 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2024 | Operating cash flow | -89582 |
|
| 2025 | Operating cash flow | -28440 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
96.8% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2024 | Liabilities / assets | 175.8% |
|
| 2025 | Liabilities / assets | 96.8% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
0.98× 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2024 | Current assets / current liabilities | 0.35× |
|
| 2025 | Current assets / current liabilities | 0.98× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2020 2020-01-01 – 2020-12-31 | −USD 17,642 Exact valueExact value: -17642 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | −USD 46,276 Exact valueExact value: -46276 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | −USD 58,348 Exact valueExact value: -58348 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | −USD 154,464 Exact valueExact value: -154464 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 111,866 Exact valueExact value: -111866 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 98,844 Exact valueExact value: -98844 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 89,582 Exact valueExact value: -89582 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | USD 155,329 Exact valueExact value: 155329 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 28,440 Exact valueExact value: -28440 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
67 filings · 1,602 latest values · 1,602 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001324759, 1324759, CERP, HGYN, edgar:1324759
Also known as Cereplast Inc, HONG YUAN HOLDING GROUP, HONG YUAN HOLDING GROUP